2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究

Abstract Background We evaluated the effects of visit‐to‐visit variability of systolic blood pressure (SBP) and diastolic blood pressure (DBP) on macrovascular and microvascular complications among patients with type 2 diabetes. Methods A total of 11 043 patients with type 2 diabetes from primary he...

Full description

Bibliographic Details
Main Authors: Ying Deng, Yin Liu, Shengchao Zhang, Hanbing Yu, Xiaozhou Zeng, Rongrong An, Zhenyuan Chen, Na Sun, Xiaoxv Yin, Yue Dong
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Journal of Diabetes
Subjects:
Online Access:https://doi.org/10.1111/1753-0407.13331
_version_ 1797951588369694720
author Ying Deng
Yin Liu
Shengchao Zhang
Hanbing Yu
Xiaozhou Zeng
Rongrong An
Zhenyuan Chen
Na Sun
Xiaoxv Yin
Yue Dong
author_facet Ying Deng
Yin Liu
Shengchao Zhang
Hanbing Yu
Xiaozhou Zeng
Rongrong An
Zhenyuan Chen
Na Sun
Xiaoxv Yin
Yue Dong
author_sort Ying Deng
collection DOAJ
description Abstract Background We evaluated the effects of visit‐to‐visit variability of systolic blood pressure (SBP) and diastolic blood pressure (DBP) on macrovascular and microvascular complications among patients with type 2 diabetes. Methods A total of 11 043 patients with type 2 diabetes from primary healthcare institutions between January 2010 and June 2020 were included. The visit‐to‐visit blood pressure variability was calculated using three metrics: SD, coefficient of variation (CV), and average real variability (ARV), obtained over a 12‐month measurement period. The associations of visit‐to‐visit blood pressure variability with macrovascular and microvascular complications were evaluated using multivariate‐adjusted Cox proportional hazards models, and hazard ratio (HR) with 95% confidence interval (CI) were reported. Results There were 330 macrovascular events and 542 microvascular events. Compared to those for participants with the lowest quartile of SD of SBP and DBP, increased risks were observed in patients with the highest quartile of SD of SBP and DBP for macrovascular complications (SD‐SBP: HR = 1.78, 95% CI: 1.24–2.57; SD‐DBP: HR = 2.20, 95% CI: 1.50–3.25) and microvascular complications (SD‐SBP: HR = 1.85, 95% CI: 1.39–2.46; SD‐DBP: HR = 1.82, 95% CI: 1.36–2.44). CV and ARV of SBP and DBP also had statistically significant associations with macrovascular and microvascular complications. The optimal variability of blood pressure target was SD of SBP <6.45 mm Hg and SD of DBP <4.81 mm Hg. Conclusions Visit‐to‐visit blood pressure variability may be a potential predictor for macrovascular and microvascular complications in patients with type 2 diabetes.
first_indexed 2024-04-10T22:32:52Z
format Article
id doaj.art-6d3bc026fc434e0c82fdf8d40fc1e7cd
institution Directory Open Access Journal
issn 1753-0393
1753-0407
language English
last_indexed 2024-04-10T22:32:52Z
publishDate 2022-11-01
publisher Wiley
record_format Article
series Journal of Diabetes
spelling doaj.art-6d3bc026fc434e0c82fdf8d40fc1e7cd2023-01-17T01:45:41ZengWileyJournal of Diabetes1753-03931753-04072022-11-01141176777910.1111/1753-0407.133312型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究Ying Deng0Yin Liu1Shengchao Zhang2Hanbing Yu3Xiaozhou Zeng4Rongrong An5Zhenyuan Chen6Na Sun7Xiaoxv Yin8Yue Dong9Department of Community Health Management Baoan Central Hospital of Shenzhen People's Republic of ChinaDepartment of Community Health Management Baoan Central Hospital of Shenzhen People's Republic of ChinaDepartment of Community Health Management Baoan Central Hospital of Shenzhen People's Republic of ChinaDepartment of Community Health Management Baoan Central Hospital of Shenzhen People's Republic of ChinaDepartment of Community Health Management Baoan Central Hospital of Shenzhen People's Republic of ChinaDepartment of Social Medicine and Health Management, School of Public Health, Tongji Medical College Huazhong University of Science and Technology Wuhan People's Republic of ChinaDepartment of Social Medicine and Health Management, School of Public Health, Tongji Medical College Huazhong University of Science and Technology Wuhan People's Republic of ChinaDepartment of Social Medicine and Health Management, School of Public Health, Tongji Medical College Huazhong University of Science and Technology Wuhan People's Republic of ChinaDepartment of Social Medicine and Health Management, School of Public Health, Tongji Medical College Huazhong University of Science and Technology Wuhan People's Republic of ChinaDepartment of Social Medicine and Health Management, School of Public Health, Tongji Medical College Huazhong University of Science and Technology Wuhan People's Republic of ChinaAbstract Background We evaluated the effects of visit‐to‐visit variability of systolic blood pressure (SBP) and diastolic blood pressure (DBP) on macrovascular and microvascular complications among patients with type 2 diabetes. Methods A total of 11 043 patients with type 2 diabetes from primary healthcare institutions between January 2010 and June 2020 were included. The visit‐to‐visit blood pressure variability was calculated using three metrics: SD, coefficient of variation (CV), and average real variability (ARV), obtained over a 12‐month measurement period. The associations of visit‐to‐visit blood pressure variability with macrovascular and microvascular complications were evaluated using multivariate‐adjusted Cox proportional hazards models, and hazard ratio (HR) with 95% confidence interval (CI) were reported. Results There were 330 macrovascular events and 542 microvascular events. Compared to those for participants with the lowest quartile of SD of SBP and DBP, increased risks were observed in patients with the highest quartile of SD of SBP and DBP for macrovascular complications (SD‐SBP: HR = 1.78, 95% CI: 1.24–2.57; SD‐DBP: HR = 2.20, 95% CI: 1.50–3.25) and microvascular complications (SD‐SBP: HR = 1.85, 95% CI: 1.39–2.46; SD‐DBP: HR = 1.82, 95% CI: 1.36–2.44). CV and ARV of SBP and DBP also had statistically significant associations with macrovascular and microvascular complications. The optimal variability of blood pressure target was SD of SBP <6.45 mm Hg and SD of DBP <4.81 mm Hg. Conclusions Visit‐to‐visit blood pressure variability may be a potential predictor for macrovascular and microvascular complications in patients with type 2 diabetes.https://doi.org/10.1111/1753-0407.13331血压大血管并发症微血管并发症2型糖尿病
spellingShingle Ying Deng
Yin Liu
Shengchao Zhang
Hanbing Yu
Xiaozhou Zeng
Rongrong An
Zhenyuan Chen
Na Sun
Xiaoxv Yin
Yue Dong
2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究
Journal of Diabetes
血压
大血管并发症
微血管并发症
2型糖尿病
title 2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究
title_full 2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究
title_fullStr 2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究
title_full_unstemmed 2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究
title_short 2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险:一项中国初级保健队列研究
title_sort 2型糖尿病患者就诊间血压变异性与大血管和微血管并发症的风险 一项中国初级保健队列研究
topic 血压
大血管并发症
微血管并发症
2型糖尿病
url https://doi.org/10.1111/1753-0407.13331
work_keys_str_mv AT yingdeng 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT yinliu 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT shengchaozhang 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT hanbingyu 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT xiaozhouzeng 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT rongrongan 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT zhenyuanchen 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT nasun 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT xiaoxvyin 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū
AT yuedong 2xíngtángniàobìnghuànzhějiùzhěnjiānxuèyābiànyìxìngyǔdàxuèguǎnhéwēixuèguǎnbìngfāzhèngdefēngxiǎnyīxiàngzhōngguóchūjíbǎojiànduìlièyánjiū